Skip to main content

Table 3 Comparison of BAL fluid cellular profile and PCR CT value in patients with PJP

From: Prognostic implication of bronchoalveolar lavage fluid analysis in patients with Pneumocystis jirovecii pneumonia without human immunodeficiency virus infection

 

Total (n = 172)

Survivor (n = 153)

Non-survivor (n = 19)

P value

Nucleated cell count, cells/μL

311.0 [214.5–563.0]

311.0 [208.5–543.5]

343.0 [240.0–635.0]

0.392

Neutrophil count, %

7.0 [2.0–21.8]

6.0 [2.0–18.0]

22.0 [2.0–46.0]

0.044

Neutrophil count, cells/μL

17.3 [5.3–83.8]

16.2 [5.1–75.3]

55.9 [10.5–268.6]

0.060

Lymphocyte count, %

39.5 [20.0–60.0]

41.0 [22.5–60.5]

24.0 [7.0–37.0]

0.001

Lymphocyte count, cells/μL

113.0 [43.6–211.5]

124.0 [51.3–227.3]

71.0 [24.2–136.6]

0.068

Eosinophil count, %

0.0 [0.0–2.0]

0.0 [0.0–2.0]

0.0 [0.0–2.0]

0.587

Eosinophil count, cells/μL

0.0 [0.0–6.5]

0.0 [0.0–7.5]

0.0 [0.0–5.0]

0.408

Macrophage count, %

40.0 [24.0–57.8]

37.0 [23.0–57.0]

48.0 [40.0–60.0]

0.087

Macrophage count, cells/μL

123.2 [62.7–222.1]

118.4 [60.2–203.9]

223.0 [112.4–292.6]

0.025

CT value in PCR (n = 178), mean ± SD

28.2 ± 4.5

28.1 ± 4.5

29.1 ± 4.1

0.368

  1. Data are expressed as median [interquartile range] unless otherwise indicated
  2. BAL, bronchoalveolar lavage; CT, cycle threshold; PCR, polymerase chain reaction; PJP, Pneumocystis jirovecii pneumonia; SD, standard deviation